drugset
drugset / Trial / NCT03444402

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

NCT03444402 ↗

Phase 1 Completed 18 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to compare pharmacokinetics and safety of CKD-381 and D026 in healthy male subjects

Timeline

Start
2018-03-02
Primary completion
2018-05-04
Completion
2018-05-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-381 Unknown — —
Subject D026 Unknown 40 mg —

Indications

gastroesophageal reflux disease